This Pharma Dividend Has Been Raised Every Single Year for Over a Decade

AbbVie has successfully navigated a major patent cliff and sustained a dividend-growth streak of more than a decade. Two strong product portfolios support expectations for continued underlying revenue growth, ongoing dividend increases and persistent share-price appreciation.

Analysis

AbbVie has successfully navigated a major patent cliff and sustained a dividend-growth streak of more than a decade. Two strong product portfolios support expectations for continued underlying revenue growth, ongoing dividend increases and persistent share-price appreciation.